Although prodromal symptoms of psychosis have long been recognized,
2 the clinical management of psychotic disorders conventionally begins at the first episode of frank psychosis, and, until recently, the period immediately preceding the first episode received relatively little attention. For the past 15 years, there has been increasing academic and clinical interest in people presenting with potentially prodromal symptoms.
3 This clinical syndrome has been termed an
at risk mental state,
4 and operationalized criteria—the
ultra high risk (UHR)
5 or
clinical high risk (HR)
6 criteria—have been developed to identify the syndrome.
4 The criteria apply to young help-seeking patients and require 1 of 3 presentations:“attenuated” psychotic symptoms, full-blown psychotic symptoms that are brief and self-limiting, or a significant decrease in functioning in the context of a genetic risk for schizophrenia.
7 Additional prodromal criteria emerging from the basic symptoms (BS) literature
8 include subjective disturbances of cognitive processing and the perception of the self and the world.
9 Belonging to one of these prodromal groups, which we hereafter term the
clinical high risk syndrome, is associated with impairments in neuropsychologic performance
10 and alterations in the structure
11-13 (for meta-analyses, see Fusar-Poli et al
14,15), function
16-18 (for meta-analyses, see Smieskova et al
19 and Fusar-Poli et al
20), connectivity,
21 and neurochemistry
22-24 of the brain.